Publication | Closed Access

Design, synthesis and biological evaluation of paralleled Aza resveratrol–chalcone compounds as potential anti-inflammatory agents for the treatment of acute lung injury

InflammationAcute Lung InjuryMedicinal ChemistryAnti-inflammatoryParalleled Aza Resveratrol–chalconeLung InflammationPharmacologyPharmacological AgentPulmonary PharmacologyPotential Anti-inflammatory AgentsPharmacotherapyAnti-cancer AgentMedicinePharmaceutical ChemistryDrug DiscoveryOxidative Stress